These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 16398679

  • 1. Hepatocellular carcinoma with silent and cirrhotic non-alcoholic steatohepatitis, accompanying ectopic liver tissue attached to gallbladder.
    Ikeda H, Suzuki M, Takahashi H, Kobayashi M, Okuse N, Moriya H, Koike J, Maeyama S, Yotsuyanagi H, Itoh F.
    Pathol Int; 2006 Jan; 56(1):40-5. PubMed ID: 16398679
    [Abstract] [Full Text] [Related]

  • 2. Hepatocellular carcinoma with nonalcoholic steatohepatitis.
    Mori S, Yamasaki T, Sakaida I, Takami T, Sakaguchi E, Kimura T, Kurokawa F, Maeyama S, Okita K.
    J Gastroenterol; 2004 Jan; 39(4):391-6. PubMed ID: 15168253
    [Abstract] [Full Text] [Related]

  • 3. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
    Cuadrado A, Orive A, García-Suárez C, Domínguez A, Fernández-Escalante JC, Crespo J, Pons-Romero F.
    Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485
    [Abstract] [Full Text] [Related]

  • 4. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.
    Yoshioka Y, Hashimoto E, Yatsuji S, Kaneda H, Taniai M, Tokushige K, Shiratori K.
    J Gastroenterol; 2004 Dec; 39(12):1215-8. PubMed ID: 15622489
    [Abstract] [Full Text] [Related]

  • 5. Steatosis and hepatocellular carcinoma risk.
    Smedile A, Bugianesi E.
    Eur Rev Med Pharmacol Sci; 2005 Dec; 9(5):291-3. PubMed ID: 16231592
    [Abstract] [Full Text] [Related]

  • 6. Surgically resected hepatocellular carcinomas in patients with non-alcoholic steatohepatitis.
    Maeda T, Hashimoto K, Kihara Y, Ikegami T, Ishida T, Aimitsu S, Fujiwara M.
    Hepatogastroenterology; 2008 Dec; 55(85):1404-6. PubMed ID: 18795699
    [Abstract] [Full Text] [Related]

  • 7. Primary liver cancers with nonalcoholic steatohepatitis.
    Hashizume H, Sato K, Takagi H, Hirokawa T, Kojima A, Sohara N, Kakizaki S, Mochida Y, Shimura T, Sunose Y, Ohwada S, Mori M.
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):827-34. PubMed ID: 17873605
    [Abstract] [Full Text] [Related]

  • 8. Nonalcoholic steatohepatitis.
    Brunt EM.
    Semin Liver Dis; 2004 Feb; 24(1):3-20. PubMed ID: 15085483
    [Abstract] [Full Text] [Related]

  • 9. Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus.
    Orikasa H, Ohyama R, Tsuka N, Eyden BP, Yamazaki K.
    J Submicrosc Cytol Pathol; 2001 Feb; 33(1-2):195-200. PubMed ID: 11686402
    [Abstract] [Full Text] [Related]

  • 10. Chronic liver disease in diabetes mellitus.
    Amarapurkar D, Das HS.
    Trop Gastroenterol; 2002 Feb; 23(1):3-5. PubMed ID: 12170918
    [Abstract] [Full Text] [Related]

  • 11. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?
    Stefano JT, de Oliveira CP, Corrêa-Giannella ML, Soares IC, Kubrusly MS, Bellodi-Privato M, de Mello ES, de Lima VM, Carrilho FJ, Alves VA.
    Liver Int; 2011 Mar; 31(3):377-85. PubMed ID: 21108736
    [Abstract] [Full Text] [Related]

  • 12. Minute scirrhous hepatocellular carcinomas undergoing different carcinogenetic processes.
    Fujii T, Zen Y, Nakanuma Y.
    Pathol Int; 2007 Jul; 57(7):443-8. PubMed ID: 17587244
    [Abstract] [Full Text] [Related]

  • 13. [Imaging of NASH].
    Tanimoto A, Tomita K.
    Nihon Rinsho; 2006 Jun; 64(6):1127-32. PubMed ID: 16768120
    [Abstract] [Full Text] [Related]

  • 14. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.
    Sorrentino P, D'Angelo S, Ferbo U, Micheli P, Bracigliano A, Vecchione R.
    J Hepatol; 2009 Feb; 50(2):351-7. PubMed ID: 19070395
    [Abstract] [Full Text] [Related]

  • 15. NASH and HCC.
    Page JM, Harrison SA.
    Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
    [Abstract] [Full Text] [Related]

  • 16. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.
    Malik SM, Gupte PA, de Vera ME, Ahmad J.
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):800-6. PubMed ID: 19281869
    [Abstract] [Full Text] [Related]

  • 17. Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver.
    von Delius S, Lersch C, Schulte-Frohlinde E, Fend F, Dobritz M, Schmid RM, Eckel F.
    Z Gastroenterol; 2006 Jan; 44(1):39-42. PubMed ID: 16397838
    [Abstract] [Full Text] [Related]

  • 18. Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?
    Chagas AL, Kikuchi LO, Oliveira CP, Vezozzo DC, Mello ES, Oliveira AC, Cella LC, Herman P, Bachella T, Caldwell SH, Alves VA, Carrilho FJ.
    Braz J Med Biol Res; 2009 Oct; 42(10):958-62. PubMed ID: 19787150
    [Abstract] [Full Text] [Related]

  • 19. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.
    Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ.
    Hepatology; 1999 Mar; 29(3):664-9. PubMed ID: 10051466
    [Abstract] [Full Text] [Related]

  • 20. Angiogenesis in chronic liver disease and its complications.
    Coulon S, Heindryckx F, Geerts A, Van Steenkiste C, Colle I, Van Vlierberghe H.
    Liver Int; 2011 Feb; 31(2):146-62. PubMed ID: 21073649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.